United States Court of Appeals for the Federal Circuit ______________________ May 1, 2012 ERRATA ______________________ Appeal Nos. 2011-1399, -1409 IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED- RELEASE CAPSULE PATENT LITIGATION --------------------------------------------------------------------------------- EURAND, INC., CEPHALON, INC., and ANESTA AG, Plaintiffs-Cross Appellants, v. MYLAN PHARMACEUTICALS INC. and MYLAN INC., Defendants-Appellants, and BARR LABORATORIES, INC., TEVA PHARMACEUTICALS USA, INC., and TEVA PHARMACEUTICAL INDUSTRIES LTD., Defendants-Appellees. ______________________ Decided: April 16, 2012 Precedential Opinion ______________________ Please make the following additions: Page 2, Of counsel on the brief for plaintiff-cross appellant was Tryn T.

Stimart, Cooley Godward Kronish LLP, of Washington, DC.

Robert L. Byer, Duane Morris LLP, of Pittsburg, Pennsylvania, for amici curiae Gregory Dolin and Robert C. Kahrl. With him on the brief were Kristina Caggiano and Elese Hanson.